Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis
Autor: | Pal Pacher, Lucas Liaudet, György Haskó, Grzegorz Godlewski, Mohanraj Rajesh, Sandor Batkai, Partha Mukhopadhyay |
---|---|
Rok vydání: | 2006 |
Předmět: |
Vascular Endothelial Growth Factor A
Cell Survival DNA repair Angiogenesis Poly ADP ribose polymerase Biophysics Angiogenesis Inhibitors Poly(ADP-ribose) Polymerase Inhibitors Biology Biochemistry Poly (ADP-Ribose) Polymerase Inhibitor Article Cell Movement Humans Enzyme Inhibitors Molecular Biology Cells Cultured Polymerase Cell Proliferation Tube formation Cell growth Angiogenesis Inhibitors/*pharmacology Benzamides/pharmacology Cell Movement/drug effects Cell Proliferation/drug effects Cell Survival/drug effects Cells Cultured Endothelium Vascular/cytology/drug effects/growth & development Enzyme Inhibitors/pharmacology Humans Phenanthrenes/pharmacology Poly(ADP-ribose) Polymerases/*antagonists & inhibitors Vascular Endothelial Growth Factor A/antagonists & inhibitors Cell Biology Phenanthrenes Cell biology Vascular endothelial growth factor A Benzamides biology.protein Cancer research Endothelium Vascular |
Zdroj: | Biochemical and Biophysical Research Communications, vol. 350, no. 2, pp. 352-7 |
ISSN: | 0006-291X |
DOI: | 10.1016/j.bbrc.2006.09.049 |
Popis: | Poly(ADP-ribose) polymerase (PARP) is a nuclear enzyme which plays an important role in regulating cell death and cellular responses to DNA repair. Pharmacological inhibitors of PARP are being considered as treatment for cancer both in monotherapy as well as in combination with chemotherapeutic agents and radiation, and were also reported to be protective against untoward effects exerted by certain anticancer drugs. Here we show that pharmacological inhibition of PARP with 3-aminobenzamide or PJ-34 dose-dependently reduces VEGF-induced proliferation, migration, and tube formation of human umbilical vein endothelial cells in vitro. These results suggest that treatment with PARP inhibitors may exert additional benefits in various cancers and retinopathies by decreasing angiogenesis. |
Databáze: | OpenAIRE |
Externí odkaz: |